Pro­to­cols: Hillary Clin­ton takes aim at drug prof­i­teers; Are­na spins out a GPCR biotech in­cu­ba­tor

An ail­ing Are­na Phar­ma­ceu­ti­cals is spin­ning out a new in­cu­ba­tor com­pa­ny called Bea­con Dis­cov­ery that will work on de­vel­op­ing a pipeline of G-Pro­tein Cou­pled …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.